Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma
- 10 June 2019
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 19 (3) , 216-227
Abstract
Background: We aimed at exploring biological functions of differentially expressed miRNAs during carcinogenesis, to identify miRNAs dysegulations involved in DNA repair mechanisms, and to evaluate potential of miRNAs as prognostic and diagnostic biomarkers for early lung adenocarcinomas (LAC).Methods: We obtained 21 LAC and paired adjacent normal formalin-fixed, paraffinembedded lung tissues from patients who underwent curative resection for stage I LAC. We compared expression levels of eight miRNAs involved in the DNA repair mechanism between LAC and adjacent tissues.Results: Expressions of Hsa-miR-9-5p, hsa-miR-24-3p, hsa-miR-125a-3p, hsa-miR- 125b-5p, hsa-miR-155-5p, and hsa-let-7a-5p were significantly up-regulated in stage I LAC tissues compared with those in the adjacent tissues. In addition, expressions of hsa-mir-9-5p, hsa-mir-24-3p, hsa-mir-125a-3p, hsa-mir-125b-5p, and hsa-mir-155-5p were significantly up-regulated in stage Ia LAC tissues, whereas expressions of hsa-mir- 125a-3p and hsa-mir-125b-5p were significantly up-regulated in stage Ib LAC tissues. Receiver operating characteristic (ROC) analysis revealed that AUROC of hsa-mir-125b- 5p was 0.875 (P < 0.001).Conclusion: Expression of hsa-mir-125b-5p could be used to distinguish LAC from adjacent tissues. Our result suggests that hsa-mir125b-5p can be a prognostic and diagnostic biomarker for LAC.Keywords
This publication has 31 references indexed in Scilit:
- MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cellsTumor Biology, 2013
- Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapyActa Pharmacologica Sinica, 2012
- miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancerJournal of Cancer Research and Clinical Oncology, 2012
- Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosisJournal of Cancer Research and Clinical Oncology, 2012
- BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological propertiesInternational Journal of Oncology, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- MicroRNA in lung cancerBritish Journal of Cancer, 2010
- Expression of dual-specificity tyrosine-(Y)-phosphorylation–regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2009
- MicroRNA expression profiles classify human cancersNature, 2005
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003